TerminatedPhase 4NCT00639951
Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation
Studying Snakebite envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Walter García, MD, MDInstituto Bioclon
- Intervention
- A(biological)
- Enrollment
- 10 target
- Eligibility
- 6-65 years · All sexes
- Timeline
- 2008 – 2009
Study locations (5)
- Hermosillo Site, Sonora, Hermosillo, Mexico
- Nayarit Site, Tepic, Nayarit, Mexico
- Hospital Universitario de la UANL "Dr. José Eleuterio González", Monterrey, Nuevo León, Mexico
- Ciudad Valles Site, Ciudad Valles, San Luis Potosí, Mexico
- Tempoal Site, Tempoal de Sánchez, Veracruz, Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00639951 on ClinicalTrials.govOther trials for Snakebite envenomation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07261982Analysis of the Efficacy of Pressure Pad vs Pressure Bandage Immobilisation for Snake Bite First Aid in Healthy Volunteers.Townsville University Hospital
- RECRUITINGNCT06304714Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French GuianaUniversity Hospital Center of Martinique